NUS Nu Skin Enterprises, Inc.Financial Income Statement
$12.20-0.21 (-1.69%)4:00 PM 05/06/24
NYSE | $USD | Post-Market: $12.20 7:00 PM
NUS Income Statement
Period
View
Order
Currency
Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||||
| Revenues | 2,420.4 | 2,581.9 | 2,695.7 | 2,225.7 | 1,969.1 | 1,969.1 | ||||||
| Other Revenues | - | - | - | - | - | - | ||||||
| Total Revenues | 2,420.4 | 2,581.9 | 2,695.7 | 2,225.7 | 1,969.1 | 1,969.1 | ||||||
| Cost Of Revenues | 581.4 | 658.0 | 675.2 | 604.0 | 546.2 | 546.2 | ||||||
| Gross Profit | 1,839.0 | 1,923.9 | 2,020.4 | 1,621.6 | 1,423.0 | 1,423.0 | ||||||
Operating Expenses & Income | ||||||||||||
| Selling General & Admin Expenses | 1,571.6 | 1,666.3 | 1,734.6 | 1,435.4 | 1,289.2 | 1,289.2 | ||||||
| Total Operating Expenses | 1,571.6 | 1,666.3 | 1,734.6 | 1,435.4 | 1,289.2 | 1,289.2 | ||||||
| Operating Income | 267.4 | 257.6 | 285.9 | 186.2 | 133.8 | 133.8 | ||||||
Earnings from Continuing Operations | ||||||||||||
| Interest Expense | (19.2) | (13.1) | (11.0) | (13.5) | (25.6) | (25.6) | ||||||
| Net Interest Expenses | (19.2) | (13.1) | (11.0) | (13.5) | (25.6) | (25.6) | ||||||
| Currency Exchange Gains (Loss) | - | - | - | - | - | - | ||||||
| Other Non Operating Income (Expenses) | 6.9 | 11.8 | (8.6) | (3.1) | 3.8 | 3.8 | ||||||
| EBT, Incl. Unusual Items | 255.2 | 256.2 | 232.5 | 89.0 | 26.6 | 26.6 | ||||||
| Income Tax Expense | 81.6 | 64.9 | 85.2 | (15.8) | 18.0 | 18.0 | ||||||
| Earnings From Continuing Operations | 173.6 | 191.4 | 147.3 | 104.8 | 8.6 | 8.6 | ||||||
Net Income | ||||||||||||
| Net Income to Company | 173.6 | 191.4 | 147.3 | 104.8 | 8.6 | 8.6 | ||||||
| Net Income | 173.6 | 191.4 | 147.3 | 104.8 | 8.6 | 8.6 | ||||||
| NI to Common Incl Extra Items | 173.6 | 191.4 | 147.3 | 104.8 | 8.6 | 8.6 | ||||||
| NI to Common Excl. Extra Items | 173.6 | 191.4 | 147.3 | 104.8 | 8.6 | 8.6 | ||||||
Supplemental Items | ||||||||||||
| Revenue Per Share | $43.60 | $49.37 | $53.71 | $44.51 | $39.61 | $39.61 | ||||||
| Basic EPS | $3.13 | $3.66 | $2.93 | $2.10 | $0.17 | $0.17 | ||||||
| Basic EPS - Continuing Ops | $3.13 | $3.66 | $2.93 | $2.10 | $0.17 | $0.17 | ||||||
| Basic Weighted Average Shares Outst. | 55.5 | 52.3 | 50.2 | 50.0 | 49.7 | 49.7 | ||||||
| Diluted EPS | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | $0.17 | ||||||
| Diluted EPS - Continuing Ops | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | $0.17 | ||||||
| Diluted Weighted Average Shares Outst. | 55.9 | 52.8 | 51.4 | 50.5 | 49.9 | 49.9 | ||||||
| Normalized Basic EPS | $2.87 | $3.06 | $3.32 | $2.12 | $1.41 | $1.41 | ||||||
| Normalized Diluted EPS | $2.85 | $3.04 | $3.24 | $2.10 | $1.40 | $1.40 | ||||||
| Dividend Per Share | $1.48 | $1.50 | $1.52 | $1.54 | $1.56 | $1.56 | ||||||
| Payout Ratio | 47.36% | 40.96% | 51.79% | 73.50% | 903.11% | 903.11% | ||||||
| EBITDA | 344.1 | 331.6 | 362.2 | 257.8 | 203.0 | 203.0 | ||||||
| EBITA | 280.8 | 267.4 | 297.6 | 195.9 | 145.7 | 145.7 | ||||||
| EBIT | 267.4 | 257.6 | 285.9 | 186.2 | 133.8 | 133.8 | ||||||
| EBITDAR | 393.0 | 383.8 | 411.3 | 303.8 | 236.4 | 236.4 | ||||||
| Effective Tax Rate | 32.0% | 25.3% | 36.6% | NM | 67.7% | 67.7% | ||||||
| Normalized Net Income | 159.5 | 160.1 | 166.4 | 106.1 | 70.0 | 70.0 | ||||||
| Interest on Long-Term Debt | 19.2 | 13.1 | 11.0 | 13.5 | 25.6 | 25.6 | ||||||
| R&D Expense From Footnotes | 30.1 | 23.3 | 27.2 | 23.3 | 22.6 | 22.6 | ||||||
| Foreign Sales | 2,095.7 | 2,156.8 | 2,155.4 | 1,688.6 | 1,455.0 | 1,455.0 | ||||||
In Millions of United States Dollar (USD) except per share items